Merck Announces Presentation of Phase III Investigational Studies Evaluating ... MarketWatch (press release) Currently available data are inadequate to determine whether concurrent use of inhaled corticosteroids or other long-term asthma control drugs mitigates the increased risk of asthma-related death from LABA. Available data from controlled clinical ... |
